AYTU BIOPHARMA, INC (AYTU) Gross margin 2016–2025
AYTU BIOPHARMA, INC (AYTU) gross margin by fiscal year — reported gross profit divided by reported revenue.
69.0%FY2025 · since FY2016: 62.6% → 69.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 69.0% | -6.2 pp |
| FY2024 | 75.3% | +13.2 pp |
| FY2023 | 62.0% | +8.0 pp |
| FY2022 | 54.1% | +9.6 pp |
| FY2021 | 44.5% | -25.5 pp |
| FY2020 | 70.0% | +0.1 pp |
| FY2019 | 69.9% | +25.9 pp |
| FY2018 | 44.0% | -12.0 pp |
| FY2017 | 56.0% | -6.6 pp |
| FY2016 | 62.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice